Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 83,520 shares at $264.01 ($21.8M) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Scheduled sale ($21.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $258.25 | 2,417 | $624K | 2.9% |
| 2 | $258.25 | 2,417 | $624K | 2.9% |
| 3 | $259.08 | 6,926 | $1.8M | 8.2% |
| 4 | $259.08 | 6,926 | $1.8M | 8.2% |
| 5 | $259.86 | 2,694 | $700K | 3.2% |
| 6 | $259.86 | 2,694 |
| $700K |
| 3.2% |
| 7 | $261.44 | 10,448 | $2.7M | 12.5% |
| 8 | $261.44 | 10,448 | $2.7M | 12.5% |
| 9 | $262.12 | 11,245 | $2.9M | 13.5% |
| 10 | $262.12 | 11,245 | $2.9M | 13.5% |
| 11 | $263.08 | 6,923 | $1.8M | 8.3% |
| 12 | $263.08 | 6,923 | $1.8M | 8.3% |
| 13 | $264.01 | 1,107 | $292K | 1.3% |
| 14 | $264.01 | 1,107 | $292K | 1.3% |
| Total | $261.29 avg | 83,520 | $21.8M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |